News
The vaccine maker, which has partnered with OpenAI since 2023, is rethinking how it does workforce planning thanks to the ...
Learn more about whether Kymera Therapeutics, Inc. or Moderna, Inc. is a better investment based on AAII's A+ Investor grades ...
More than 3,000 GPTs are reportedly in use at Moderna, which has partnered with OpenAI. Here's how they're using the technology.
Moderna’s combined Covid and flu shot outperformed the existing standalone vaccines for both viruses, according to the ...
The Associated Press on MSN7d
Moderna study shows immune response in older adults for a combo flu and COVID-19 shotA combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...
We recently published a list of Billionaire David E. Shaw’s 10 Small-Cap Stock Picks with Huge Upside Potential. In this ...
Moderna’s Chief People & Digital Officer, Tracey Franklin, has become the latest high-profile executive to reveal how agentic ...
Moderna on Thursday reported first-quarter profit and sales that beat Wall Street estimates, helped by the company's ...
Moderna is being audited by the PMCPA after yet again being found to have brought discredit on the pharma industry, putting ...
MM+M Women of Distinction honoree, announced Monday morning that she has joined Medtronic Diabetes as its chief marketing ...
The Wall Street Journal on MSN13d
Moderna Posts Loss, Citing Seasonality of Respiratory BusinessModerna MRNA2.15%increase; green up pointing triangle logged a first-quarter loss as revenue fell, dragged down by lower ...
Biotechnology company Moderna (NASDAQ:MRNA) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 35.3% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results